Increase in anti-inflammatory activities of radical-degraded porphyran (cas 11016-36-7)s isolated from discolored nori (Pyropia yezoensis)
-
Add time:08/17/2019 Source:sciencedirect.com
The anti-inflammatory properties of porphyrans (D1–D4) obtained from four discolored nori (Pyropia yezoensis) with different growth backgrounds were studied to examine possible variations in their bioactivities. Elution profiles of the porphyrans on Sepharose 4B indicated that D2-porphyran had relatively lower-molecular-size porphyrans than the other porphyrans. Inhibitory activities of the four porphyrans against nitric oxide (NO) and tumor necrosis factor-α (TNF-α) secretion by lipopolysaccharide (LPS)-stimulated RAW264.7 cells were different, whereas no significant differences were observed in the sulfate and anhydrogalactose levels. D2-porphyran showed the highest inhibitory activity against NO and TNF-α secretion by LPS-stimulated RAW264.7 cells, whereas D3- and D4-porphyrans had almost no activity. All porphyrans were efficiently degraded by free radical generated with ascorbate and hydrogen peroxide. The free-radical degradation resulted in a significant increase in the inhibitory activities of the four porphyrans against NO and TNF-α secretion, with varying rates depending on the porphyrans. The ability of D2-porphyran to suppress the receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells was also significantly enhanced after degradation. Our results suggest that molecular size is an important factor affecting the anti-inflammatory activity of porphyrans, and radical degradation might be a promising procedure to obtain active low-molecular-size porphyrans.
We also recommend Trading Suppliers and Manufacturers of porphyran (cas 11016-36-7). Pls Click Website Link as below: cas 11016-36-7 suppliers
Prev:Comparative analysis of prebiotic effects of seaweed polysaccharides laminaran, porphyran (cas 11016-36-7), and ulvan using in vitro human fecal fermentation
Next:In vivo antihyperlipidemic and antioxidant activity of porphyran (cas 11016-36-7) in hyperlipidemic mice) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and drug release in vitro of porphyran (cas 11016-36-7) carrying 5-Fluorouracil08/25/2019
- Investigation of the factors influencing the molecular weight of porphyran (cas 11016-36-7) and its associated antifungal activity08/24/2019
- Immuno-modulation effect of sulphated polysaccharide (porphyran (cas 11016-36-7)) from Porphyra vietnamensis08/23/2019
- In vitro antioxidant activities of acetylated, phosphorylated and benzoylated derivatives of porphyran (cas 11016-36-7) extracted from Porphyra haitanensis08/22/2019
- Regioselective syntheses of sulfated porphyran (cas 11016-36-7)s from Porphyra haitanensis and their antioxidant and anticoagulant activities in vitro08/21/2019
- Antioxidant and anti-inflammatory activities of porphyran (cas 11016-36-7) isolated from discolored nori (Porphyra yezoensis)08/20/2019
- Protective effect of porphyran (cas 11016-36-7) isolated from discolored nori (Porphyra yezoensis) on lipopolysaccharide-induced endotoxin shock in mice08/19/2019
- In vivo antihyperlipidemic and antioxidant activity of porphyran (cas 11016-36-7) in hyperlipidemic mice08/18/2019
- Comparative analysis of prebiotic effects of seaweed polysaccharides laminaran, porphyran (cas 11016-36-7), and ulvan using in vitro human fecal fermentation08/16/2019


